Abstract:Author summary Multiple members in a family can be diagnosed with the same disease. In such families, genetics may be a significant factor in disease risk. However, it remains unclear whether such familial aggregation of disease is likely due to a single highly penetrant rare variant (HPRV), many minimally penetrant common variants, or a combination of the two types of variants. We therefore use recent estimates of SNP heritability and the liability threshold model to estimate the proportion of afflicted families likely to carry a rare, causal variant. We then show that Polygenic Risk Scores (PRS) may be useful for identifying families likely to carry such a rare variant and introduce a related statistic that can be used to select families for sequencing studies trying to identify HPRV. Despite genetics being accepted as the primary cause of familial aggregation for most diseases, it is still unclear whether afflicted families are likely to share a single highly penetrant rare variant, many minimally penetrant common variants, or a combination of the two types of variants. We therefore use recent estimates of SNP heritability and the liability threshold model to estimate the proportion of afflicted families likely to carry a rare, causal variant. We then show that Polygenic Risk Scores (PRS) may be useful for identifying families likely to carry such a rare variant and therefore for prioritizing families to include in sequencing studies with that aim. Specifically, we introduce a new statistic that estimates the proportion of individuals carrying causal rare variants based on the family structure, disease pattern, and PRS of genotyped individuals. Finally, we consider data from the MelaNostrum consortium and show that, despite an estimated PRS heritability of only 0.05 for melanoma, families carrying putative causal variants had a statistically significantly lower PRS, supporting the idea that PRS prioritization may be a useful future tool. However, it will be important to evaluate whether the presence of rare mendelian variants are generally associated with the proposed test statistic or lower PRS in future and larger studies.

Inferring disease risk genes from sequencing data in multiplex pedigrees through sharing of rare variants

Mapping structural variants to rare disease genes using long-read whole genome sequencing and trait-relevant polygenic scores

RetroFun-RVS: a retrospective family-based framework for rare variant analysis incorporating functional annotations

Contribution of Common Genetic Variants to Familial Aggregation of Disease and Implications for Sequencing Studies.

Statistics to prioritize rare variants in family-based sequencing studies with disease subtypes

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

TRIO RVEMVS: A Bayesian framework for rare variant association analysis with expectation-maximization variable selection using family trio data

Methods for Association Analysis and Meta‐Analysis of Rare Variants in Families

Approach of Fusing Multiple Tests to Analyzing Rare Genetic Variants

A Unified Framework for Detecting Rare Variant Quantitative Trait Associations in Pedigree and Unrelated Individuals Via Sequence Data

Estimating Genetic Effects and Quantifying Missing Heritability Explained by Identified Rare-Variant Associations

Avidity sequencing of whole genomes from retinal degeneration pedigrees identifies causal variants

Rare coding variant analysis for human diseases across biobanks and ancestries

A Variational Bayes Discrete Mixture Test for Rare Variant Association

RVTESTS: an Efficient and Comprehensive Tool for Rare Variant Association Analysis Using Sequence Data.

A Probabilistic Method for Identifying Rare Variants Underlying Complex Traits

Pangenome graphs improve the analysis of structural variants in rare genetic diseases

A Robust Model-free Approach for Rare Variants Association Studies Incorporating Gene-Gene and Gene-Environmental Interactions

[Family-Based Association Tests for Rare Variants].

Integrative Analysis of Sequencing and Array Genotype Data for Discovering Disease Associations with Rare Mutations

Exome-based mapping and variant prioritization for inherited Mendelian disorders